High-fat diet consumption triggered cellular senescence in mouse hippocampi, marked by elevated p16/p21 expression, increased senescence-associated secretory phenotype (SASP) factors, and reduced Lamin B1. Palmitate, the dominant saturated fatty acid in these diets, emerged as the primary culprit driving both senescent cell accumulation and cognitive deficits. The senolytic combination of dasatinib (a tyrosine kinase inhibitor) plus quercetin (a flavonoid) successfully cleared senescent hippocampal cells and restored memory function. This finding bridges two critical areas: the obesity-neurodegeneration connection and the emerging field of senolytic therapeutics for brain health. The work provides compelling mechanistic evidence that dietary saturated fats don't just contribute to metabolic dysfunction but directly age brain tissue through cellular senescence pathways. While promising, the mouse model limits immediate clinical translation. The doses and long-term safety of this drug combination in humans remain unclear. Nevertheless, this represents a paradigm shift toward viewing cognitive decline from poor diet as a targetable senescence-driven process rather than just inflammation or metabolic dysfunction.